CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study
Ju Hwan Kim, Yeon-Hee Baek, Hyesung Lee, Young June Choe, Hyun Joon Shin, Ju-Young Shin
Epidemiol Health. 2021;43:e2021004  Published online December 29, 2020
DOI: https://doi.org/10.4178/epih.e2021004

Excel Download

End-stage renal disease and adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among patients with diabetes
The Journal of Clinical Hypertension. 2017;19(6):627-631   Crossref logo
Link1 Link2

A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
European Heart Journal - Cardiovascular Pharmacotherapy. 2020;7(2):148-157   Crossref logo
Link1 Link2 Link3

Angiotensin-converting enzyme inhibitors (ACEI) or Angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
. 2020;   Crossref logo
Link1 Link2

Angiotensin-Converting Enzyme Inhibitors (ACEI) or Angiotensin Receptor Blockers (ARBs) May Be Safe for COVID-19 Patients
. 2020;   Crossref logo
Link1 Link2

A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
Therapeutics and Clinical Risk Management. 2009;547   Crossref logo
Link1

Angiotensinā€Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Africanā€American Patients With Hypertension
The Journal of Clinical Hypertension. 2004;6(6):310-314   Crossref logo
Link1 Link2 Link3 Link4

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
Clinical Science. 2021;135(8):1009-1014   Crossref logo
Link1 Link2

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(4):349-350   Crossref logo
Link1 Link2

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
Encyclopedia of Heart Diseases. 2006;61-67   Crossref logo
Link1 Link2

Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
Journal of Travel Medicine. 2020;27(3):   Crossref logo
Link1 Link2 Link3